Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
What are Semaglutide and Tirzepatide Weight Loss Medications
Ozempic (active ingredient semaglutide) is a prescription medication manufactured by Novo Nordisk that is FDA approved to improve glycemic control in adults with Type 2 diabetes
In the pivotal SUSTAIN trials examining semaglutide for type 2 diabetes management, vomiting was reported in 5-9% of patients receiving therapeutic doses (0.5 mg or 1 mg weekly subcutaneous injections), compared to approximately 2-3% in placebo groups
Their active ingredient, semaglutide, belongs to a class of GLP-1 receptor agonists that work to reduce weight by mimicking a naturally occurring hormone that signals your body to feel full and slows digestion by increasing the time it takes for food to leave the body
US$ 24.06
US$ 24.19
US$ 28.54
